Engagement with officials on issues related to the National Strategy for Rare Disease Drugs, and other policies or programs related to rare diseases.
Politique ou Programme
Santé
Federally-funded public drug plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Politique ou Programme
Budget, Santé
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations.
Politique ou Programme
Santé, Industrie, Propriété intellectuelle
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.
Politique ou Programme, Règlement
Santé, Industrie
Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda and other government policies and programs related to incentivizing research and development activities in Canada, including the Biomanufacturing and Life Sciences Strategy.
Politique ou Programme
Santé
Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada review of drugs for rare diseases.
